Haematologica · 2008 · 72 citations · 14 references
Life SciencesGeneticsMolecular GeneticsBiochemical GeneticsHuman GeneticsMedical GeneticsClinical HematologyGenetic DisordersHematologic DisordersRed Blood Cell DisordersAdult PrevalenceHemoglobin Synthesis DefectsHemoglobinopathy ScreeningHigh-risk Population PrevalenceMolecular Diagnosis Of HemoglobinopathiesPopulation Screening For Hemoglobinopathies
We report a retrospective analysis carried out on 23,485 subjects submitted to a screening program from 2000 to 2006. Of these subjects, 3,934 had borderline HbA(2) values from 3.1 to 3.9%; 410 samples, analyzed previously using PCR methods and sequencing because all of these were partners of a carrier of classical beta-thalassemia, were selected for statistical analysis. Of 410 subjects, 94 (22.9%) were positive for a molecular defect in the beta-, delta- or alpha-globin genes. The most prevalent molecular defects were beta IVS1 nt 6 (HBB c.92+6T C), co-inheritance of severe beta thalassemia and delta mutations, beta-promoter mutations and triplication of alpha genes were detected; alpha-thalassemia and Hb-variants were also evident. Borderline HbA(2) is not a rare event in a population with a high prevalence of beta-thalassemia carriers. These data support the necessity to investigate these cases at a molecular level, particularly if the partner is a carrier of beta-thalassemia.
14
Triplicated alpha-globin loci in humans.
M. Goossens, A M Dozy, Stephen H. Embury et al. · Proceedings of the National Academy of Sciences · 1980 · 241 citations · Full text
Initiation codon mutation as a cause of alpha thalassemia.
Mario Pirastu, Giuseppe Saglio, Judy C. Chang et al. · Journal of Biological Chemistry · 1984 · 129 citations · Full text